| Nome |
# |
|
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection, file e268c4c9-ab16-a6b7-e053-3a05fe0adea1
|
503
|
|
Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults: A Systematic Review and Meta-analysis, file e268c4cb-a10d-a6b7-e053-3a05fe0adea1
|
482
|
|
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial, file e268c4cd-55b9-a6b7-e053-3a05fe0adea1
|
385
|
|
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?, file e268c4cb-6be4-a6b7-e053-3a05fe0adea1
|
226
|
|
Role of pharmacists in antimicrobial stewardship programmes, file e268c4cb-820a-a6b7-e053-3a05fe0adea1
|
204
|
|
Management of KPC-producing Klebsiella pneumoniae infections, file e268c4c9-ec77-a6b7-e053-3a05fe0adea1
|
195
|
|
Treatment of Infections Due to MDR Gram-Negative Bacteria, file e268c4ca-6fc0-a6b7-e053-3a05fe0adea1
|
125
|
|
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project, file e268c4ca-8641-a6b7-e053-3a05fe0adea1
|
122
|
|
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections, file e268c4ca-3ffc-a6b7-e053-3a05fe0adea1
|
120
|
|
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead, file e268c4cb-c89e-a6b7-e053-3a05fe0adea1
|
107
|
|
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus, file e268c4c9-e19e-a6b7-e053-3a05fe0adea1
|
106
|
|
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy, file e268c4ca-4fb4-a6b7-e053-3a05fe0adea1
|
106
|
|
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study, file e268c4ca-4fb6-a6b7-e053-3a05fe0adea1
|
105
|
|
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals, file e268c4ca-71a3-a6b7-e053-3a05fe0adea1
|
103
|
|
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file e268c4c9-a504-a6b7-e053-3a05fe0adea1
|
101
|
|
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e268c4c9-f0d0-a6b7-e053-3a05fe0adea1
|
101
|
|
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials, file e268c4cb-abb9-a6b7-e053-3a05fe0adea1
|
93
|
|
Influence of age on the clinical efficacy of tigecycline in severely ill patients, file e268c4cb-a91a-a6b7-e053-3a05fe0adea1
|
91
|
|
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?, file e268c4cb-356f-a6b7-e053-3a05fe0adea1
|
82
|
|
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study, file e268c4c7-a08b-a6b7-e053-3a05fe0adea1
|
79
|
|
Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience, file e268c4cb-390c-a6b7-e053-3a05fe0adea1
|
79
|
|
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study, file e268c4cb-c0d2-a6b7-e053-3a05fe0adea1
|
78
|
|
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial, file e268c4cb-b02c-a6b7-e053-3a05fe0adea1
|
77
|
|
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project, file e268c4cc-0dfb-a6b7-e053-3a05fe0adea1
|
77
|
|
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file e268c4c9-a4f0-a6b7-e053-3a05fe0adea1
|
76
|
|
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review, file e268c4cb-e55a-a6b7-e053-3a05fe0adea1
|
76
|
|
Management of vertebral osteomyelitis over an eight-year period: The UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis), file e268c4cb-17b3-a6b7-e053-3a05fe0adea1
|
74
|
|
Update on new research in Gram-negative infections European Congress of Clinical Microbiology and Infectious Diseases 2017 (22-25 April, Vienna, Austria), file e268c4cc-0c56-a6b7-e053-3a05fe0adea1
|
73
|
|
Use of colistin in adult patients: a cross-sectional study, file e268c4c9-d54c-a6b7-e053-3a05fe0adea1
|
70
|
|
Analysis of pooled phase 3 safety data for delafloxacin in acute bacterial skin and skin structure infections, file e268c4cb-a916-a6b7-e053-3a05fe0adea1
|
68
|
|
Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: A position paper from an Italian working group on CRE infections, file e268c4cb-038f-a6b7-e053-3a05fe0adea1
|
67
|
|
Ceftobiprole: drug evaluation and place in therapy, file e268c4cb-6a79-a6b7-e053-3a05fe0adea1
|
67
|
|
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?, file e268c4cb-038d-a6b7-e053-3a05fe0adea1
|
65
|
|
Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole, file e268c4cc-14bc-a6b7-e053-3a05fe0adea1
|
65
|
|
Combating resistance while maintaining innovation: the future of antimicrobial stewardship, file e268c4cb-5d37-a6b7-e053-3a05fe0adea1
|
63
|
|
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus, file e268c4cb-44b1-a6b7-e053-3a05fe0adea1
|
61
|
|
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation, file e268c4cb-c153-a6b7-e053-3a05fe0adea1
|
61
|
|
Procalcitonin levels in candidemia versus bacteremia: A systematic review, file e268c4cb-056e-a6b7-e053-3a05fe0adea1
|
60
|
|
The global challenge of Candida auris in the intensive care unit, file e268c4cb-a90e-a6b7-e053-3a05fe0adea1
|
60
|
|
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections, file e268c4cb-9571-a6b7-e053-3a05fe0adea1
|
59
|
|
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management, file e268c4ca-6281-a6b7-e053-3a05fe0adea1
|
55
|
|
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis, file e268c4ca-6fbe-a6b7-e053-3a05fe0adea1
|
54
|
|
Correction to: Procalcitonin levels in candidemia versus bacteremia: A systematic review (Critical Care (2019) 23 (190) DOI: 10.1186/s13054-019-2481-y), file e268c4cb-6333-a6b7-e053-3a05fe0adea1
|
54
|
|
Intensive care medicine research agenda on invasive fungal infection in critically ill patients, file e268c4cb-9f55-a6b7-e053-3a05fe0adea1
|
54
|
|
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP), file e268c4cc-2e0a-a6b7-e053-3a05fe0adea1
|
54
|
|
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy, file e268c4ca-64fc-a6b7-e053-3a05fe0adea1
|
53
|
|
Epidemiology of Strongyloides stercoralis in northern Italy: Results of a multicentre case-control study, February 2013 to July 2014, file e268c4cb-e046-a6b7-e053-3a05fe0adea1
|
53
|
|
Machine learning and multidrug-resistant gram-negative bacteria: An interesting combination for current and future research, file e268c4cc-1366-a6b7-e053-3a05fe0adea1
|
53
|
|
Development of an integrated environmental monitoring protocol for SARS-CoV-2 contamination. Applications at the IRCSS San Martino Polyclinic Hospital in Genoa, Italy, file e268c4ce-8050-a6b7-e053-3a05fe0adea1
|
53
|
|
NGS barcode sequencing in taxonomy and diagnostics, an application in "Candida" pathogenic yeasts with a metagenomic perspective, file e268c4cb-e54c-a6b7-e053-3a05fe0adea1
|
52
|
|
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement, file e268c4c6-c215-a6b7-e053-3a05fe0adea1
|
49
|
|
Erratum to “Intensive care management of influenza-associated pulmonary aspergillosis” (Clinical Microbiology and Infection (2019) 25(12) (1501–1509), (S1198743X19302095), (10.1016/j.cmi.2019.04.031)), file e268c4cc-27b9-a6b7-e053-3a05fe0adea1
|
48
|
|
Erratum to: Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation [Biol Blood Marrow Transplant (2017) 23 (333–339)] (S1083879116304839) (10.1016/j.bbmt.2016.11.005), file e268c4cb-c14b-a6b7-e053-3a05fe0adea1
|
46
|
|
Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: Data from the prospective multicenter Italian endocarditis study cohort, file e268c4cb-d8a9-a6b7-e053-3a05fe0adea1
|
46
|
|
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial, file e268c4cc-3abe-a6b7-e053-3a05fe0adea1
|
43
|
|
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/ extensively drug-resistant/pandrug-resistant bacteria, file e268c4cb-820e-a6b7-e053-3a05fe0adea1
|
40
|
|
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections, file e268c4cb-d9dd-a6b7-e053-3a05fe0adea1
|
39
|
|
Characterization of T lymphocytes in severe COVID-19 patients, file e268c4cf-1350-a6b7-e053-3a05fe0adea1
|
36
|
|
Task force on management and prevention of Acinetobacter baumannii infections in the ICU, file e268c4cb-ce4c-a6b7-e053-3a05fe0adea1
|
35
|
|
Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study, file e268c4cd-55bb-a6b7-e053-3a05fe0adea1
|
33
|
|
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers, file e268c4ce-f803-a6b7-e053-3a05fe0adea1
|
30
|
|
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies, file e268c4cb-b2fc-a6b7-e053-3a05fe0adea1
|
28
|
|
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy, file e268c4cc-c929-a6b7-e053-3a05fe0adea1
|
25
|
|
Overview of Fungal Infections - The Italian Experience, file e268c4cb-8c65-a6b7-e053-3a05fe0adea1
|
24
|
|
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study, file e268c4cd-d181-a6b7-e053-3a05fe0adea1
|
24
|
|
Cardiac point-of-care ultrasound in hospitalized coronavirus disease-2019 patients: findings and association with outcome, file e268c4ce-2ee6-a6b7-e053-3a05fe0adea1
|
23
|
|
A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality, file e268c4cb-badb-a6b7-e053-3a05fe0adea1
|
20
|
|
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors, file e268c4ce-9d89-a6b7-e053-3a05fe0adea1
|
20
|
|
Delafloxacin: An improved fluoroquinolone developed through advanced molecular engineering, file e268c4cc-0c52-a6b7-e053-3a05fe0adea1
|
18
|
|
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective, file e268c4cd-90dc-a6b7-e053-3a05fe0adea1
|
18
|
|
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?, file e268c4cb-843d-a6b7-e053-3a05fe0adea1
|
17
|
|
Current and future therapies for invasive aspergillosis, file e268c4cb-8c7b-a6b7-e053-3a05fe0adea1
|
16
|
|
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients, file e268c4cb-b55a-a6b7-e053-3a05fe0adea1
|
16
|
|
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file e268c4cb-f28d-a6b7-e053-3a05fe0adea1
|
16
|
|
The burden of severe cases of Influenza disease: The Friuli Venezia Giulia Region experience, file e268c4cb-1699-a6b7-e053-3a05fe0adea1
|
14
|
|
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach, file e268c4cb-9f4f-a6b7-e053-3a05fe0adea1
|
14
|
|
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections, file e268c4cb-a111-a6b7-e053-3a05fe0adea1
|
13
|
|
Mycobacterium tuberculosis Surgical Site Infection after Cardiac Surgery in the COVID-19 Era: A Case Report, file e268c4ce-8b18-a6b7-e053-3a05fe0adea1
|
13
|
|
Development of novel antibacterial drugs to combat multiple resistant organisms, file e268c4cb-8c73-a6b7-e053-3a05fe0adea1
|
12
|
|
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy, file e268c4cb-9742-a6b7-e053-3a05fe0adea1
|
11
|
|
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort, file e268c4cb-d7d5-a6b7-e053-3a05fe0adea1
|
11
|
|
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”, file e268c4cc-8bad-a6b7-e053-3a05fe0adea1
|
11
|
|
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy, file e268c4cd-f66b-a6b7-e053-3a05fe0adea1
|
11
|
|
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection, file 4c590e71-c430-4115-ad09-465bf06a05f0
|
10
|
|
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2, file 8b10f9e0-4157-4a63-a9aa-e6204ca1a8a1
|
10
|
|
The COVID-19 insidious trick: Subjective perception of numbers, file e268c4cd-7014-a6b7-e053-3a05fe0adea1
|
10
|
|
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network, file 9b956d61-09d0-4221-9267-da34592ddd87
|
9
|
|
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy, file e268c4cc-105f-a6b7-e053-3a05fe0adea1
|
9
|
|
A Wide Database for a Multicenter Study on Pneumocystis jirovecii Pneumonia in Intensive Care Units, file 70fcd282-7e8f-41b0-8bd5-d9cea486654e
|
8
|
|
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact, file 8667f211-1d12-4413-996c-d35c93fae18d
|
8
|
|
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience, file e268c4c7-e6b7-a6b7-e053-3a05fe0adea1
|
8
|
|
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation, file e268c4cb-bad7-a6b7-e053-3a05fe0adea1
|
8
|
|
Eravacycline for the treatment of intra-abdominal infections, file e268c4cb-d9ea-a6b7-e053-3a05fe0adea1
|
8
|
|
Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia, file e268c4cc-039f-a6b7-e053-3a05fe0adea1
|
8
|
|
null, file e268c4cd-7625-a6b7-e053-3a05fe0adea1
|
8
|
|
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia, file eb013e88-73cb-4784-ad6c-2d656c026b83
|
8
|
|
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study, file e268c4c7-eb30-a6b7-e053-3a05fe0adea1
|
7
|
|
ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies, file e268c4cb-0566-a6b7-e053-3a05fe0adea1
|
7
|
|
Surgical Complications Requiring an Early Relaparotomy in HIV-Infected Liver Transplant Recipients: Risk Factors and Impact on Survival, file e268c4cb-3572-a6b7-e053-3a05fe0adea1
|
7
|
|
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant, file e268c4cb-90cb-a6b7-e053-3a05fe0adea1
|
7
|
| Totale |
6.307 |